Search Results

There are 8219 results for: content related to: Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment

  1. You have free access to this content
    Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP-1 and TIMP-2 and tumor thrombospondin-1

    International Journal of Cancer

    Volume 136, Issue 3, 1 February 2015, Pages: 721–729, Romina Dossi, Roberta Frapolli, Silvana Di Giandomenico, Lara Paracchini, Fabio Bozzi, Silvia Brich, Vittoria Castiglioni, Patrizia Borsotti, Dorina Belotti, Sarah Uboldi, Roberta Sanfilippo, Eugenio Erba, Raffaella Giavazzi, Sergio Marchini, Silvana Pilotti, Maurizio D'Incalci and Giulia Taraboletti

    Version of Record online : 19 JUN 2014, DOI: 10.1002/ijc.29023

  2. You have free access to this content
    Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis® (PM00104)

    International Journal of Cancer

    Volume 133, Issue 9, November 2013, Pages: 2024–2033, Michela Romano, Roberta Frapolli, Monique Zangarini, Ezia Bello, Luca Porcu, Carlos M. Galmarini, Luis F. García-Fernández, Carmen Cuevas, Paola Allavena, Eugenio Erba and Maurizio D'Incalci

    Version of Record online : 25 MAY 2013, DOI: 10.1002/ijc.28213

  3. Tumor associated macrophages and neutrophils in tumor progression

    Journal of Cellular Physiology

    Volume 228, Issue 7, July 2013, Pages: 1404–1412, Maria R. Galdiero, Cecilia Garlanda, Sébastien Jaillon, Gianni Marone and Alberto Mantovani

    Version of Record online : 21 MAR 2013, DOI: 10.1002/jcp.24260

  4. Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repair

    International Journal of Cancer

    Volume 139, Issue 2, 15 July 2016, Pages: 467–479, Dominique Harnicek, Eric Kampmann, Kirsten Lauber, Roman Hennel, Ana Sofia Cardoso Martins, Yang Guo, Claus Belka, Simone Mörtl, Eike Gallmeier, Roland Kanaar, Ulrich Mansmann, Tomas Hucl, Lars H. Lindner, Wolfgang Hiddemann and Rolf D. Issels

    Version of Record online : 25 MAR 2016, DOI: 10.1002/ijc.30070

  5. You have free access to this content
    Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents

    International Journal of Cancer

    Volume 131, Issue 1, 1 July 2012, Pages: 59–69, S. Uboldi, S. Bernasconi, M. Romano, S. Marchini, I. Fuso Nerini, G. Damia, M. Ganzinelli, E. Marangon, F. Sala, L. Clivio, G. Chiorino, S. Di Giandomenico, M. Rocchi, O. Capozzi, G.P. Margison, A.J. Watson, A.M. Caccuri, A. Pastore, A. Fossati, R. Mantovani, F. Grosso, J.C. Tercero, E. Erba and M. D'Incalci

    Version of Record online : 30 AUG 2011, DOI: 10.1002/ijc.26340

  6. Macrophage Polarization: Anti-cancer Strategies to Target Tumor-associated Macrophage in Breast Cancer

    Journal of Cellular Biochemistry

    Accepted manuscript online: 20 JAN 2017, Muhammad Tariq, Jieqiong Zhang, Guikai Liang, Ling Ding, Qiaojun He and Bo Yang

    DOI: 10.1002/jcb.25895

  7. You have free access to this content
    Trabectedin has promising antineoplastic activity in high-grade meningioma


    Volume 118, Issue 20, 15 October 2012, Pages: 5038–5049, Matthias Preusser, Sabine Spiegl-Kreinecker, Daniela Lötsch, Adelheid Wöhrer, Maria Schmook, Karin Dieckmann, Walter Saringer, Christine Marosi and Walter Berger

    Version of Record online : 5 MAR 2012, DOI: 10.1002/cncr.27460

  8. A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors

    Pediatric Blood & Cancer

    Volume 59, Issue 5, November 2012, Pages: 865–869, Meredith K. Chuk, Alberta Aikin, Trish Whitcomb, Brigitte C. Widemann, Peter Zannikos, Eliel Bayever, Frank M. Balis and Elizabeth Fox

    Version of Record online : 27 JUL 2012, DOI: 10.1002/pbc.24201

  9. Mechanism-based Pharmacokinetic/Pharmacodynamic Meta-analysis of Trabectedin (ET-743, Yondelis) Induced Neutropenia

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 1, January 2008, Pages: 130–143, J Hing, J J Perez-Ruixo, K Stuyckens, A Soto-Matos, L Lopez-Lazaro and P Zannikos

    Version of Record online : 27 JUN 2007, DOI: 10.1038/sj.clpt.6100259

  10. You have free access to this content
    Myeloid cells in hepatocellular carcinoma


    Volume 62, Issue 4, October 2015, Pages: 1304–1312, Shanshan Wan, Ning Kuo, Ilona Kryczek, Weiping Zou and Theodore H. Welling

    Version of Record online : 1 JUL 2015, DOI: 10.1002/hep.27867

  11. You have free access to this content
    Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway

    British Journal of Pharmacology

    Volume 170, Issue 4, October 2013, Pages: 871–882, Sandra Martínez, Laura Pérez, Carlos M Galmarini, Miguel Aracil, Juan C Tercero, Federico Gago, Beatriz Albella and Juan A Bueren

    Version of Record online : 1 OCT 2013, DOI: 10.1111/bph.12331

  12. You have free access to this content
    ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma


    Volume 117, Issue 15, 1 August 2011, Pages: 3445–3456, Antoine Italiano, Armelle Laurand, Audrey Laroche, Paolo Casali, Roberta Sanfilippo, Axel Le Cesne, Ian Judson, Jean-Yves Blay, Isabelle Ray-Coquard, Binh Bui, Jean-Michel Coindre, Antonio Nieto, Juan-Carlos Tercero, Jose Jimeno, Jacques Robert and Philippe Pourquier

    Version of Record online : 1 FEB 2011, DOI: 10.1002/cncr.25925

  13. Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in nucleotide excision repair (NER)-deficient and NER-proficient cells, unravelled by a novel mathematical simulation approach

    Cell Proliferation

    Volume 40, Issue 6, December 2007, Pages: 885–904, M. Tavecchio, C. Natoli, P. Ubezio, E. Erba and M. D’Incalci

    Version of Record online : 15 NOV 2007, DOI: 10.1111/j.1365-2184.2007.00469.x

  14. Extreme sensitivity to Yondelis® (Trabectedin, ET-743) in low passaged sarcoma cell lines correlates with mutated p53

    Journal of Cellular Biochemistry

    Volume 100, Issue 2, 1 February 2007, Pages: 339–348, Victoria Moneo, Beatriz G. Serelde, Jesús Fominaya, Juan F.M. Leal, Carmen Blanco-Aparicio, Lourdes Romero, Margarita Sánchez-Beato, Juan C. Cigudosa, Juan C. Tercero, Miguel A. Piris, Jose Jimeno and Amancio Carnero

    Version of Record online : 3 AUG 2006, DOI: 10.1002/jcb.21073

  15. Complete remission of recurrent ovarian clear cell carcinoma by chemotherapy with bevacizumab, trabectedin and oxaliplatin

    Journal of Obstetrics and Gynaecology Research

    Volume 39, Issue 4, April 2013, Pages: 872–875, Masashi Takano, Yuji Ikeda, Kazuya Kudoh, Tsunekazu Kita, Naoki Sasaki and Yoshihiro Kikuchi

    Version of Record online : 20 NOV 2012, DOI: 10.1111/j.1447-0756.2012.02047.x

  16. You have free access to this content
    Anti-tumour strategies aiming to target tumour-associated macrophages


    Volume 138, Issue 2, February 2013, Pages: 93–104, Xiaoqiang Tang, Chunfen Mo, Yongsheng Wang, Dandan Wei and Hengyi Xiao

    Version of Record online : 16 JAN 2013, DOI: 10.1111/imm.12023

  17. Role of Tumor-Associated Macrophages (TAM) in Cancer Related Inflammation

    Tumor Microenvironment

    Antonio Sica, Chiara Porta, Pages: 77–98, 2010

    Published Online : 30 AUG 2010, DOI: 10.1002/9780470669891.ch5

  18. The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma

    Journal of Surgical Oncology

    Volume 111, Issue 5, April 1, 2015, Pages: 622–631, David A. Liebner

    Version of Record online : 8 JAN 2015, DOI: 10.1002/jso.23866

  19. You have free access to this content
    PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity

    British Journal of Pharmacology

    Volume 161, Issue 5, November 2010, Pages: 1099–1110, JFM Leal, M Martínez-Díez, V García-Hernández, V Moneo, A Domingo, JA Bueren-Calabuig, A Negri, F Gago, MJ Guillén-Navarro, P Avilés, C Cuevas, LF García-Fernández and CM Galmarini

    Version of Record online : 2 JUL 2010, DOI: 10.1111/j.1476-5381.2010.00945.x

  20. You have free access to this content
    Poster Sessions

    European Journal of Immunology

    Volume 39, Issue S1, September 2009, Pages: S55–S279,

    Version of Record online : 19 AUG 2009, DOI: 10.1002/eji.200990224